Suppression of osteoclastogenesis via α2-adrenergic receptors.
Hamajima K, Hamamura K, Chen A, Yokota H, Mori H, Yo S, Kondo H, Tanaka K, Ishizuka K, Kodama D, Hirai T, Miyazawa K, Goto S, Togari A.
Hamajima K, et al.
Biomed Rep. 2018 May;8(5):407-416. doi: 10.3892/br.2018.1075. Epub 2018 Mar 9.
Biomed Rep. 2018.
PMID: 29725523
Free PMC article.